News & Updates
Filter by Specialty:
Phototherapy for psoriasis at home as good as in the office
Narrowband ultraviolet B (NB-UVB) phototherapy or light therapy performed at home is as good as one done in the doctor’s office in patients with plaque and guttate psoriasis, as shown in the randomized Light Treatment Effectiveness (LITE) trial presented at EADV 2024.
Phototherapy for psoriasis at home as good as in the office
15 Oct 2024
Psoriasis patients with overweight, obesity may need higher vunakizumab dosage
In the treatment of moderate-to-severe psoriasis, patients with overweight or obesity appear to have a diminished response to vunakizumab compared with those who have lower BMIs, according to a post hoc subgroup analysis of a phase III trial.
Psoriasis patients with overweight, obesity may need higher vunakizumab dosage
14 Oct 2024
Ebdarokimab works wonders for patients with plaque psoriasis
A recent study has shown the safety and efficacy of AK 101 (ebdarokimab) in the treatment of patients with plaque psoriasis, achieving ≥75-percent improvement in Psoriasis Area and Severity Index (PASI 75) and Static Physicians Global Assessment (sPGA) 0/1 response.
Ebdarokimab works wonders for patients with plaque psoriasis
14 Oct 2024
Risankizumab eases symptoms in nonpustular palmoplantar psoriasis
In patients with nonpustular palmoplantar psoriasis (nPPP), treatment with risankizumab relieves disease symptoms, such as skin pain in palms or soles of feet, by week 16, as shown by the results of a post hoc analysis of the phase IIIb IMMprint study. These improvements persist up to week 52.
